Last update 08 Apr 2026

PM8102

Overview

Basic Info

Drug Type
Biological products
Synonyms
BNT-3214, BNT-3214, PM8102
Target-
Action-
Mechanism-
Therapeutic Areas
Neoplasms
Active Indication
Advanced Malignant Solid NeoplasmLocally Advanced Malignant Solid Neoplasm
Inactive Indication-
Originator Organization
Bio-Entech (Guangdong Hengqin) Pharmaceutical Co., Ltd.BioNTech (Shanghai) Pharmaceuticals Co., Ltd.
Active Organization
BioNTech SEBioNTech SEBio-Entech (Guangdong Hengqin) Pharmaceutical Co., Ltd.BioNTech (Shanghai) Pharmaceuticals Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with PM8102
NCT07455734
/ RecruitingPhase 1/2
A Phase I/IIa, First-in-human, Open-label, Multi-site, Multi-regional, Dose Escalation Trial With Expansion Cohorts to Evaluate Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors
100 Clinical Results associated with PM8102
Login to view more data
100 Translational Medicine associated with PM8102
Login to view more data
100 Patents (Medical) associated with PM8102
Login to view more data
100 Deals associated with PM8102
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 2
South Korea
Bio-Entech (Guangdong Hengqin) Pharmaceutical Co., Ltd.
30 Mar 2026
Advanced Malignant Solid NeoplasmPhase 2
South Korea
BioNTech (Shanghai) Pharmaceuticals Co., Ltd.
30 Mar 2026
Locally Advanced Malignant Solid NeoplasmPhase 2
China
BioNTech SEBioNTech SE
30 Mar 2026
Locally Advanced Malignant Solid NeoplasmPhase 2
Australia
BioNTech SEBioNTech SE
30 Mar 2026
Locally Advanced Malignant Solid NeoplasmPhase 2
Taiwan Province
BioNTech SEBioNTech SE
30 Mar 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free